Effectiveness and safety of 7-day high-dose primaquine and single-dose tafenoquine versus 14-day low-dose primaquine in patients with Plasmodium vivax malaria (EFFORT): a multicentre, open-label, randomised, controlled, superiority trial. (linkinghub.elsevier.com)

Authors: Degaga TS … Thriemer K Journal: Lancet Infectious Diseases Published: 2026-06-01 DOI: https://doi.org/10.1016/S1473-3099(25)00729-7